Europe needs and deserves healthcare systems that take a modern approach to both demand and delivery. 21st century healthcare systems should benefit to meet the needs of European countries; countries faced with unprecedented challenges of growth, public finance, employment and solidarity. The vision of the biopharmaceutical industry is one of cooperation and partnerships, maximizing the benefits we can deliver to society together through developing innovative medicines.
We support a vision of modern, sustainable healthcare systems in Europe. Systems providing patients with equal and early access to the best and safest medicines; which support innovation and realistically balance benefit and risk; which empower citizens to make informed decisions about their health and ensure the highest security of the medicines supply chain. Such a vision will also assist policymakers in sustaining Europe’s economic growth and competitiveness by balancing healthcare budgets and helping to provide a healthy and productive workforce and to address the unique challenges of Europe’s demographic deficit. It also offers the most effective approach to deliver the innovative medicines needed to tackle current and potential health threats.
The key contribution of the pharmaceutical industry:
The biopharmaceutical industry contributes many benefits to Europe and its citizens. It is committed to:
- Better quality healthcare and treatment choices by responding to unmet medical needs;
- Value solutions that meet national healthcare and social security budgets;
- Investment in innovation in Europe, bringing highly skilled employment and contributing economic benefits.
Reducing inequalities in health, accelerating patients’ access to innovative medicines and improving patient safety. We seek to work in partnership with all relevant healthcare stakeholders to develop practical solutions to making this a reality.
We believe that Europe’s Citizens support these commitments, creating a mutual agenda. We therefore call upon stakeholders to collaborate in implementing policies that recognize the biopharmaceutical industry’s role in improving European public health, economic wealth, and in enhancing Europe’s industrial and science base .
Together, we will help create a healthcare sector fit for the 21st century.